Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2004
11/03/2004EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/03/2004EP1339716B1 lactam-substituted pyrazolopyridine derivatives
11/03/2004EP1169338B1 Low-molecular inhibitors of complement proteases
11/03/2004EP1105371B1 Novel aryl sulphonamide amino acid esters and analogues
11/03/2004EP0888118B1 Enhancement of microbial colonisation of the gastrointestinal tract
11/03/2004EP0877748B1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/03/2004EP0729325B1 Osteogenic product and use
11/03/2004CN1543464A Novel imidazopyridine compounds with therapeutic effect
11/03/2004CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/03/2004CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004CN1543358A Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
11/03/2004CN1543347A Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine
11/03/2004CN1543345A Methods for selective immunomodulation using pimecrolimus
11/03/2004CN1543343A Preparation and diabetic use of gibberellins
11/03/2004CN1543342A Controlled heat induced rapid delivery of pharmaceuticals from skin depot
11/03/2004CN1542010A Azolo triazines and pyrimidines
11/03/2004CN1541711A Regulation of immune responses by manipulation of intermediary metabolite levels
11/03/2004CN1541697A Chinese traditional medicine soft capsule for treating chronic cholecystitis and gallstone, and its preparation
11/03/2004CN1541696A Oyster capsule for gastric disease and its preparation
11/03/2004CN1541691A Acute icterohepatitis treating Chinese traditional medicine and its preparation
11/03/2004CN1541688A Traditional Chinese medicine preparation for treating nonspecific colonitis and its preparing process
11/03/2004CN1541680A Chinese traditional medicinal composition Weitashen for replenishing qi, invigorating spleen, calming heart and tranquilizing mind
11/03/2004CN1541674A Traditional Chinese drugs fomula for removing alliaceous odor of mouth cavity rapidly
11/03/2004CN1541673A Kidney nourishing medicated wine
11/03/2004CN1541669A Prepared traditional Chinese drug Liangfu drop pills for treating epigastric pain
11/03/2004CN1541665A Sustained release medicine for treating hepatitis and its preparing process
11/03/2004CN1541657A Medicinal periplaneta americana extracturm extracting process
11/03/2004CN1541651A Unit dosage glycyrrhizicacid diammonium freeze-dry powder injection formulation and its preparation method
11/03/2004CN1173992C Hybrid peptide with vascularization inhibiting activity
11/03/2004CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
11/03/2004CN1173969C Novel lipoic acid derivatives, their preparation method and medical use, and pharmaceutical compositions containing them
11/03/2004CN1173743C Compositions for treatment of disorders of the oesophagus
11/03/2004CN1173738C Utilization of interferon alpha 5 in the preparation of drugs for viral hepatopathies
11/03/2004CN1173731C Use of Traditonal Chinese medicine composition for curing chronic hepatitis B fibrosis in preparation of medicine for pulmonary fibrosis of SARS
11/03/2004CN1173715C Medicine pill for preventing and treating pathological senility
11/03/2004CN1173711C Donkey-hide gelatin capsule
11/03/2004CN1173705C Use of ª‰-2-hydroxymethyl-5-(5-fluctyosine-1-yl)-1,3-oxathialane in preparation of medicine and composition containing same
11/03/2004CN1173689C Decayed tooth preventing Magnolia Officinalis toothpaste
11/02/2004US6812253 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
11/02/2004US6812236 Compounds useful in therapy
11/02/2004US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression
11/02/2004US6812219 Methods and compositions for treating flaviviruses and pestiviruses
11/02/2004US6812210 Urocortin-III and uses thereof
11/02/2004US6811781 Composition and method for diagnosing auto-immune hepatitis
11/02/2004US6811769 Oral composition, method of making the oral composition and oral hygiene method in japanese and chinese herbal remedy
11/02/2004CA2338704C Oral liquid mucoadhesive compositions
11/02/2004CA2329486C Reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars
11/02/2004CA2296970C Neuropeptide y antagonists
11/02/2004CA2296313C 2-aminopyridines containing fused ring substituents as nos inhibitors
11/02/2004CA2103454C Macrocyclic immunomodulators
10/2004
10/28/2004WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004WO2004092169A1 Spiropiperidine compound and medicinal use thereof
10/28/2004WO2004092163A1 Phenylazole compound, production process, and antioxidant drug
10/28/2004WO2004092153A1 Diamine derivative, production process, and antioxidizing drug
10/28/2004WO2004092136A1 Nitrogenous heterocyclic compound and use thereof
10/28/2004WO2004092128A1 Anhydrous crystalline forms of (2s, 4s)-1-{(2r)-2-amino-3-‘4-methoxybenzyl)sulfonyl!-3-methylbutanoyl}-4-fluoropyrrolindine-2-carbonitrile
10/28/2004WO2004092118A2 2-propylidene-19-nor-vitamin d compounds
10/28/2004WO2004091665A1 Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist
10/28/2004WO2004091661A1 Remedy for diabetes
10/28/2004WO2004091643A1 Agent for increasing granulocyte macrophage colony stimulating factor
10/28/2004WO2004091628A1 Receptor antagonist
10/28/2004WO2004091622A1 The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome
10/28/2004WO2004091611A1 Carbonic anhydrase inhibitors to eradicate helicobacter pylori
10/28/2004WO2004091599A1 Method for the treatment of diseases linked to an accumulation of triglycerides and cholesterol
10/28/2004WO2004091598A1 Use of beta-aminoisobutyric acid for the treatment of diseases linked to the accumulation of triglycerides and cholesterol
10/28/2004WO2004091597A2 Method of treating irritable bowel syndrome (ibs)
10/28/2004WO2004072643A3 Diagnostics and therapeutics for diseases associated with glucagon-like peptide 2 receptor (glp2r)
10/28/2004WO2004069806A3 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
10/28/2004WO2004067093A3 Nk1 receptor antagonists for the treatment of functional dyspepsia
10/28/2004WO2004064716A3 Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders
10/28/2004WO2004047925A3 Therapeutic oxidation catalysts
10/28/2004WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/28/2004WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis
10/28/2004WO2003077840A3 Method of modulating inflammatory response
10/28/2004WO2003018515A3 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
10/28/2004WO2001081540A3 Growth factor which acts through erb b-4 rtk
10/28/2004US20040215171 Ingestible device for the release of substances at distinct locations in alimentary canal
10/28/2004US20040215021 Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
10/28/2004US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders
10/28/2004US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis
10/28/2004US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same
10/28/2004US20040214886 for the treatment and/or prophylaxis of diseases, in particular, states of pain and neurodegenerative disorders
10/28/2004US20040214875 Imidazolinylmethyl aralkylsulfonamides
10/28/2004US20040214871 Treating cancer with a synergistic mixtures; anticarcinogenic agents; epothilone has secondary amide instead of an ester
10/28/2004US20040214864 Novel compounds
10/28/2004US20040214852 Polysubstituted imidazopyridines
10/28/2004US20040214844 N4-acylcytosine nucleosides for treatment of viral infections
10/28/2004US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer
10/28/2004US20040214839 administering prostaglandin or agonist thereof and type IV selective phosphodiesterase (PDE) inhibitor to induce tolerance to antigens
10/28/2004US20040214830 2,7-Substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors
10/28/2004US20040214822 Substituted 4-aminocyclohexanol compounds
10/28/2004US20040214815 Therapeutic compounds
10/28/2004US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004US20040214794 perorally or rectally administering an effective amount of a lipopolysaccharide isolated from Escherichia coli
10/28/2004US20040214782 caused by infection from Eimeria bovis, Eimeria zuernii or E. aubernensis; administering macrolide antibiotics, azalide class, such as tilmicosin
10/28/2004US20040214780 Peptide derivative, and pharmaceutically acceptable salt thereof, process for producing the same, and use thereof
10/28/2004US20040214759 Compositions and methods of use for a fibroblast growth factor
10/28/2004US20040214746 Pharmaceutical composition of a tachykinin receptor antagonist
10/28/2004US20040214275 Von willebrand factor (vmf)-cleaving enzyme
10/28/2004US20040214234 Method